SUBSCRIBE
SUBSCRIBE
Biotech Beach

Abraxis BioScience, Inc. Launches ABRAXANE in Germany

February 4, 2009 | 
1 min read

LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, today announced the launch in Germany of ABRAXANE, 5 mg/ml powder for suspension for infusion (paclitaxel).

MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Biotech Beach
The ABCs of Biopharma This Week: ASCO, BIO and Cancer
June 5, 2024
 · 
1 min read
 · 
Greg Slabodkin, Heather McKenzie, Tyler Patchen
Pictured: Woman carrying box of office things
Business
BIO24 Kicks Off in San Diego as City’s Biotech Hub Gets Hit with Jobs Downturn
June 3, 2024
 · 
5 min read
 · 
Tyler Patchen